2025-11-17T16:23:08-06:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 293 EISENHOWER PARKWAY 2ND FLOOR LIVINGSTON NJ 07039 990 2024-01-01 820547746 LIFE RAFT GROUP INC LIFE 9738379092 155 US HIGHWAY 46 WEST 202 WAYNE NJ 07470 SARA ROTHSCHILD EXEC. DIRECTOR 9738379092 2025-11-17 1 0 BRIDGET HARTNETT P01429163 9739949494 2025-11-17 2024 2025-03-06 01:10:19Z SARA ROTHSCHILD 155 US HIGHWAY 46 WEST 202 WAYNE NJ 07470 2312458 0 X WWW.LIFERAFTGROUP.ORG X 2002 NJ ENHANCING SURVIVAL AND QUALITY OF LIFE FOR PEOPLE LIVING WITH GIST AND OTHER RARE CANCERS THROUGH PATIENT-POWERED RESEARCH, EDUCATION, EMPOWERMENT AND GLOBAL ADVOCACY EFFORTS. THE VISION IS TO CHAMPION PATIENT-POWERED SCIENCE AND DRASTICALLY INCREASE LONG-TERM SURVIVORSHIP FOR GIST CANCER PATIENTS. 12 12 17 215 0 0 1569132 2089809 79742 0 136128 166851 76964 -76871 1861966 2179789 20000 25000 0 0 1213721 1186153 0 0 69807 478566 559000 1712287 1770153 149679 409636 3244046 3761480 283523 301915 2960523 3459565 ENHANCING SURVIVAL AND QUALITY OF LIFE FOR PEOPLE LIVING WITH GIST AND OTHER RARE CANCERS THROUGH PATIENT-POWERED RESEARCH, EDUCATION, EMPOWERMENT AND GLOBAL ADVOCACY EFFORTS. 0 0 1141896 25000 RESEARCH: WE FUND AND MANAGE UNIQUELY COORDINATED RESEARCH INITIATIVES THAT ALWAYS KEEP THE NEEDS OF GIST PATIENTS FOREMOST. THE LIFE RAFT GROUP (LRG) CONTINUES TO LEAD A COLLABORATIVE TEAM OF WORLD-RENOWNED SCIENTISTS AND CLINICIANS IN GIST. LRG HAS THE LARGEST GIST PATIENT REGISTRY IN THE WORLD. OUR RESEARCH PARADIGM IS PATIENT-POWERED SCIENCE FOR LIFE. A COMPREHENSIVE APPROACH THAT COMPLIMENTS TRADITIONAL RESEARCH WITH REAL WORLD EVIDENCE SUPPORTED BY DATA. 488643 INFORMATION, EDUCATION, ADVOCACY, OUTREACH & ENGAGEMENT: THE LRG PROVIDES SUPPORT, INTERVENTION, EDUCATION AND ADVOCACY TO GIST PATIENTS, THEIR FAMILIES, AND CAREGIVERS. LOCAL SUPPORT IS AVAILABLE TO THE GIST COMMUNITY THROUGH A NETWORK OF LRG MENTORS AND VOLUNTEERS. OUR EDUCATION PROGRAMS ARE OFFERED WORLDWIDE. OUR GIST DAYS OF LEARNING ANDOUR BIENNIAL LIFE FEST EVENT GATHER EXPERTS FROM ACROSS THE GLOBE TO BRING THE MOST UP TO DATE INFORMATION ON GIST RESEARCH, EMERGING THERAPIES AND UPDATES ON THE WORLD OF GIST. OUR OUTREACH AND ENGAGEMENT EFFORTS ALSO INCLUDE PATIENT SUPPORT GROUPS, FOCUS GROUPS, MONTHLY WEBCASTS, OUR WEBSITE, ACCESS TO OUR CLINICAL TRIALS DATABASE AND OUR WORLDWIDE GIST SPECIALIST DATABASE. EXPERT PATIENT TRAINING IS OFFERED TO ALL MEMBERS. 1630539 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 17 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 0 0 NJ X X X THE ORGANIZATION 9738379092 155 US HIGHWAY 46 WEST 202 WAYNE NJ 07470 STAN BUNN TRUSTEE 1.00 X 0 0 0 JIM HUGHES TRUSTEE 1.00 X 0 0 0 CHRISTA PEREIRA TRUSTEE 1.00 X 0 0 0 JOHN ABRAMS TRUSTEE 1.00 X 0 0 0 TEENA PETERSOHN TRUSTEE 1.00 X 0 0 0 GARY GLASSER PRESIDENT 1.00 X X 0 0 0 STEVE PONTELL TRUSTEE 1.00 X 0 0 0 KAY STOLZER TRUSTEE 1.00 X 0 0 0 DR MONICA ANDERSON TRUSTEE 1.00 X 0 0 0 SANTY DISABATINO BOARD MEMBER & TREASURER 1.00 X X 0 0 0 PATRICIA BONDA-SWENSON TRUSTEE 1.00 X 0 0 0 BILL BORWEGEN TRUSTEE 1.00 X 0 0 0 ROBIN ELIA CONTROLLER 30.00 X 73829 0 3947 LAURA OCCHIUZZI DEPUTY EXECUTIVE DIRECTOR 35.00 X 131915 0 7021 SARA ROTHSCHILD EXECUTIVE DIRECTOR 40.00 X 144660 0 10586 350404 0 21554 2 0 1 0 0 140510 1949299 2089809 166851 166851 46205 140510 132669 -86464 -86464 OTHER 900099 9593 9593 9593 2179789 0 0 89980 X 25000 25000 371958 342202 14878 14878 673822 619916 26953 26953 8317 7651 333 333 34993 32195 1399 1399 97063 89297 3883 3883 6265 5763 251 251 40380 37150 1615 1615 335802 308938 13432 13432 3635 3345 145 145 37692 34676 1508 1508 8547 7863 342 342 28580 26294 1143 1143 33163 30509 1327 1327 1220 1122 49 49 1697 1561 68 68 MEETINGS/EDUCATIONAL SE 43608 40120 1744 1744 COMMUNICATIONS 12143 11171 486 486 PRINTING & PUBLICATIONS 3792 3488 152 152 POSTAGE 2476 2278 99 99 1770153 1630539 69807 69807 -1 864659 623636 60910 213354 2382 7123 42306 36226 410 6080 2240613 2868450 75073 42837 3244046 3761480 212537 263119 70986 38796 283523 301915 X 2396817 2432060 563706 1027505 2960523 3459565 3244046 3761480 409636 -1565 90971 0 X X 0 1 X 1 0 X 1996886 1875368 1313670 1569132 2089809 8844865 1996886 1875368 1313670 1569132 2089809 8844865 3554382 5290483 13518 1027 41019 130698 166851 353113 599 79 667 9593 10938 9208916 533575 0.57450 0.58790 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 599. 2021 AMOUNT: $ 79. 2022 AMOUNT: $ 667. 2024 AMOUNT: $ 9,593. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 42306 36226 6080 6080 LEASE LIABILITY 38796 38796 X 2310893 -1565 -1565 2312458 -132669 -132669 2179789 1902822 132669 132669 1770153 0 1770153 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501 (C)(3) OF THE INTERNAL REVENUE CODE. THE ORGANIATION FOLLOWS ACCOUNTING STANDARDS THAT PROVIDE CLARIFICATION ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. THE GUIDANCE PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, AND ALSO PROVIDES GUIDANCE ON DE-RECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES, DISCLOSURE AND TRANSITION. THE ORGANIZATION'S POLICY IS TO RECOGNIZE INTEREST AND PENALTIES ON UNRECOGNIZED TAX BENEFITS IN INCOME TAX EXPENSE. NO INTEREST AND PENALTIES WERE RECORDED DURING THE YEAR ENDED DECEMBER 31, 2024. AT DECEMBER 31, 2024, THERE ARE NO SIGNIFICANT INCOME TAX UNCERTAINTIES. PART XI, LINE 4B - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE -132,669. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES 132,669. LIFE FEST 157716 140510 17206 73679 7519 27849 WATER OF LIFE 26504 26504 15249 2 2495 2495 8373 186715 140510 46205 73679 7519 51471 132669 -86464 1 SARCOMA ALLIANCE FOR RESEARCH THROUGH COLLABORATION (SARC) PO BOX 406 ANN ARBOR MI 48106 861087705 501 C 3 25000 0 RESEARCH GRANT 1 PART I, LINE 2: ORGANIZATION RECEIVES RESEARCH REPORTS BY GRANTEE. X 0 0 0 0 0 0 0 0 0 SARA ROTHSCHILD EXECUTIVE DIRECTOR 144660 0 0 0 0 0 3986 0 6600 0 155246 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS FIRST REVIEWED BY THE CONTROLLER, THEN BY THE EXECUTIVE DIRECTOR AFTER DISCUSSION WITH THE CONTROLLER. IT IS ALSO SENT TO THE BOARD TREASURER AND THE BOARD PRESIDENT AND ANY QUESTIONS OR COMMENTS ARE DISCUSSED WITH THE EXECUTIVE DIRECTOR AND CONTROLLER. FORM 990, PART VI, SECTION B, LINE 12C POTENTIAL CONFLICTS ARE DISCUSSED ANNUALLY AT A BOARD MEETING. FORM 990, PART VI, SECTION B, LINE 15A AT LEAST ONCE A YEAR THE EXECUTIVE DIRECTOR MEETS TO REVIEW AND DISCUSS REPORTS OF COMPARABLE NON-PROFIT SALARIES PREPARED BY INDEPENDENT ORGANIZATIONS. THIS REVIEW PROVIDES THE GUIDELINES FOR REVIEWING AND APPROVING ANY SALARY RECOMMENDATIONS PROPOSED BY THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 18 THE ORGANIZATION MAKES ITS FORM 1023 AND 990 AVAILABLE FOR PUBLIC INSPECTION THROUGH THE ORGANIZATION'S WEBSITE, UPON REQUEST AND VIA WWW.GUIDESTAR.ORG. FORM 990, PART VI, SECTION C, LINE 19 ALL GOVERNING DOCUMENTS, INCLUDING A CONFLICT OF INTEREST POLICY (PART OF BY-LAWS), AND FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE AND ARE ALSO MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 308,938. MANAGEMENT AND GENERAL EXPENSES 13,432. FUNDRAISING EXPENSES 13,432. TOTAL EXPENSES 335,802. FORM 990, PART XII, LINE 2C: NO CHANGE IN THE OVERSIGHT OR SELECTION PROCESS FROM THE PRIOR YEAR.